Press Releases

Roswell Park and partners launch Roswell Park Care Network
Tuesday, May 21, 2019
Roswell Park Comprehensive Cancer Center joined today with hospitals, health systems, physicians and supportive care teams from across the state, all committed to reducing the burden of cancer, to announce the launch of the Roswell Park Care Network.
Promotion will see Dr. Elizabeth Bouchard facilitating efforts to identify, address health disparities
Monday, May 20, 2019
Elizabeth Bouchard, PhD, has been promoted to Associate Director for Community Outreach and Engagement at Roswell Park Comprehensive Cancer Center.
Dr. Rodney Haring celebrated for influencing health of Indigenous communities
Tuesday, May 14, 2019

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center faculty researcher Rodney Haring, PhD, MSW, has been recognized with a Research Into Action Award from the Robert Wood Johnson Foundation’s (RWJF) New Connections initiative. 

Wednesday, May 8, 2019
If you’re a nurse and have imagined yourself working at Roswell Park Comprehensive Cancer Center, the center’s nursing open house on May 13 is the right place to start that journey. Take an opportunity to learn about oncology nursing and hear from those who work at Roswell Park.
Wednesday, May 8, 2019
A clinical trial underway at Roswell Park Comprehensive Cancer Center will assess a brand-new immunotherapy approach in patients with cancer of the ovaries, fallopian tubes or peritoneum that has recurred despite earlier treatment.
Friday, May 3, 2019
James D. Newman has been named the new Chair of the Roswell Park Alliance Foundation, the 501(c)(3) not-for-profit organization that manages all donations made to Roswell Park Comprehensive Cancer Center.
Tuesday, April 30, 2019
As Roswell Park Comprehensive Cancer Center continues to grow, so does our leadership team. Newly appointed Chair of Diagnostic Radiology Ermelinda Bonaccio, MD, has announced several recent promotions within the department.
Monday, April 29, 2019
Generous donations have set in motion five groundbreaking new research projects at Roswell Park Comprehensive Cancer Center this spring.
Friday, April 19, 2019
Roswell Park Comprehensive Cancer Center has added a new leader to its Department of Pathology and Laboratory Medicine with the promotion of Paul Bogner, MD, to Director of Surgical Pathology.
Thursday, April 18, 2019
Roswell Park Comprehensive Cancer Center and Oneida Healthcare have received a $1 million gift from an anonymous donor to their joint capital campaign.
Tuesday, April 16, 2019
One of the mechanisms that makes so-called triple-negative breast cancer (TNBC) notoriously aggressive and hard to treat is its ability to disarm proteins that suppress tumors and mutate them into tumor drivers. Seeking to better understand this process, a team from Roswell Park Comprehensive Cancer Center decided to focus not on what these TNBC tumors lack but something they possess: an alternate estrogen receptor, ER-beta. In a new article in JNCI: Journal of the National Cancer Institute, they report that a widely used breast cancer drug, tamoxifen, can turn the ER-beta protein into a double agent capable of disrupting the processes that typically make TNBC tumors so devastating.